| Molecular formula | C27H44N4O5 |
|---|
| Molecular weight | 504.7 g/mol |
|---|
| Registered trials | 0 |
|---|
| PubChem CID | 129010512 |
|---|
Dihexa is a synthetic compound studied only in early research settings, not an approved medical product. Anyone encountering claims about it should know what is and is not established.
Regulatory status
Dihexa has no FDA-approved label and is classified here as unapproved research material. There is no brand name, no approved indication, and no established clinical use.
What dihexa is
Chemically, dihexa has the molecular formula C27H44N4O5 and a molecular weight of about 504.7. Its structure is catalogued in PubChem under CID 129010512. No FDA label, mechanism statement, or drug class designation exists for this compound in the data reviewed.
Trial footprint
There are no registered clinical trials for dihexa in the data reviewed. No trial samples, phases, or statuses are available to report at this time.
FAQ
No. Dihexa has no FDA-approved label and is not an approved medical product. It is classified as an unapproved research compound.
There is no approved use for dihexa. No clinical indication, dosing guidance, or approved application exists based on available data.
The data reviewed shows no registered clinical trials for dihexa. There is currently no trial footprint to summarize.
Dihexa has the molecular formula C27H44N4O5 and a molecular weight of approximately 504.7. It is catalogued in PubChem under CID 129010512.
No adverse event reporting data is available for dihexa in the sources reviewed. This means no side effect pattern can be summarized at this time.
This page is an editorial information resource. It does not sell, prescribe, or recommend any medication.
Content is editorial information, not medical advice. Talk to your doctor before any treatment decision.
Sources: PubChem
Updated 2026-09-19